Literature DB >> 6238338

EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers.

G R McClelland, P Raptopoulos.   

Abstract

The quantitative electroencephalogram (EEG) and plasma concentration of the antidepressant paroxetine were monitored in five normal volunteers after a single oral dose of 70 mg paroxetine and placebo. Peak plasma concentration occurred 4-6 h post-dose. Placebo had little effect on the EEG but the effects of paroxetine were statistically significant at 6 h post-dose. The EEG changes after treatment consisted of a decrease in delta and theta activity (less than 8 Hz) and increase in beta activity (greater than 12 Hz). These changes were still evident 72 h after treatment. The EEG profile obtained with 70 mg paroxetine is similar to that reported for other antidepressant 5-HT uptake inhibitors, but dissimilar to the classical, sedative antidepressants.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238338     DOI: 10.1007/bf00428539

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property.

Authors:  E N Petersen; S O Olsson; R F Squires
Journal:  Eur J Pharmacol       Date:  1977-06-01       Impact factor: 4.432

2.  Potent and long-lasting potentiation of two 5-hydroxytryptophan- induced effects in mice by three selective 5-ht uptake inhibitors.

Authors:  J B Lassen
Journal:  Eur J Pharmacol       Date:  1978-02-01       Impact factor: 4.432

3.  EEG, blood level, and behavioral effects of the antidepressant mianserin (ORG GB-94).

Authors:  M Fink; P Irwin; M Gastpar; J J DeRidder
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

4.  Spectral difference index: a single EEG measure of drug effect.

Authors:  P Irwin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-09

5.  Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).

Authors:  T M Itil; N Polvan; W Hsu
Journal:  Curr Ther Res Clin Exp       Date:  1972-07

6.  Potent depletion of 5HT from monkey whole blood by a new 5HT uptake inhibitor, paroxetine (FG 7051).

Authors:  E N Petersen; E Bechgaard; R J Sortwell; L Wetterberg
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

7.  Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.

Authors:  C J Klok; G J Brouwer; H M van Praag; D Doogan
Journal:  Acta Psychiatr Scand       Date:  1981-07       Impact factor: 6.392

8.  Paroxetine: pharmacokinetics, tolerance and depletion of blood 5-HT in man.

Authors:  J Lund; B Lomholt; J Fabricius; J A Christensen; E Bechgaard
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-04

9.  Influence of the new 5-HT-uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-7-tyramine (H 77/77).

Authors:  J B Lassen
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

Review 10.  Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R C Heel; P A Morley; R N Brogden; A A Carmine; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

View more
  7 in total

1.  Prevalence and correlates of alpha-delta sleep in major depressive disorders.

Authors:  Nattapong Jaimchariyatam; Carlos L Rodriguez; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2011-07

Review 2.  Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.

Authors:  K L Dechant; S P Clissold
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 3.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

4.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

5.  A comparison of the gastric and central nervous system effects of two substituted benzamides in normal volunteers.

Authors:  G R McClelland; J A Sutton
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

6.  Exploring diazepam's effect on hemodynamic responses of mouse brain tissue by optical spectroscopic imaging.

Authors:  David Abookasis; Ariel Shochat; Elimelech Nesher; Albert Pinhasov
Journal:  Biomed Opt Express       Date:  2014-06-11       Impact factor: 3.732

7.  Physiologically Based Pharmacokinetic Modeling to Describe the CYP2D6 Activity Score-Dependent Metabolism of Paroxetine, Atomoxetine and Risperidone.

Authors:  Simeon Rüdesheim; Dominik Selzer; Thomas Mürdter; Svitlana Igel; Reinhold Kerb; Matthias Schwab; Thorsten Lehr
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.